wherein: R1 is an optionally substituted 4-, 5- or 6-membered heterocyclic ring having one or more heteroatoms, in which at least one carbon atom of the ring is substituted with O or S; X1 is —CO— or —CS— or —CH2CO— or CH(R4) wherein R4 is H or optionally substituted alkyl or —COOH or —COOR11 wherein R11 is optionally substituted alkyl; X2 and X3 (which may be the same or different) are —CO— or —CS—; Z is —CH2— or —S—or —O— or —NH—; Q is O or S; R2 is H or optionally substituted alkyl or an optionally substituted carbocyclic ring; R3 is H or optionally substituted alkyl or an optionally substituted mono- or polycyclic ring, optionally having one or more heteroatoms in the ring(s) and optionally being a fused ring; or R2 and R3 together form an optionally substituted mono- or polycyclic ring optionally having one or more heteroatoms in the ring(s) and optionally being a fused ring; R5 and R6 (which may be the same or different) are H, or lower alkyl; R7 and R8 (which may be the same or different) are H, or optionally substituted lower alkyl; R9 and R10 (which may be the same or different) are H, or optionally substituted alkyl, or an optionally substituted carbocyclic ring; Y is —(CH2)n— where n is 0, 1, 2 or 3 provided that when R2 and R3 form part of the ring n is 0; and pharmaceutically acceptable salts thereof. "/>
TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme
首页>
外国专利>
TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme
TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme
展开▼
机译:TRH样肽衍生物作为TRH降解外酶的抑制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
Peptide derivatives useful as inhibitors of activity of thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) are of formula Ia: wherein: R1 is an optionally substituted 4-, 5- or 6-membered heterocyclic ring having one or more heteroatoms, in which at least one carbon atom of the ring is substituted with O or S; X1 is —CO— or —CS— or —CH2CO— or CH(R4) wherein R4 is H or optionally substituted alkyl or —COOH or —COOR11 wherein R11 is optionally substituted alkyl; X2 and X3 (which may be the same or different) are —CO— or —CS—; Z is —CH2— or —S—or —O— or —NH—; Q is O or S; R2 is H or optionally substituted alkyl or an optionally substituted carbocyclic ring; R3 is H or optionally substituted alkyl or an optionally substituted mono- or polycyclic ring, optionally having one or more heteroatoms in the ring(s) and optionally being a fused ring; or R2 and R3 together form an optionally substituted mono- or polycyclic ring optionally having one or more heteroatoms in the ring(s) and optionally being a fused ring; R5 and R6 (which may be the same or different) are H, or lower alkyl; R7 and R8 (which may be the same or different) are H, or optionally substituted lower alkyl; R9 and R10 (which may be the same or different) are H, or optionally substituted alkyl, or an optionally substituted carbocyclic ring; Y is —(CH2)n— where n is 0, 1, 2 or 3 provided that when R2 and R3 form part of the ring n is 0; and pharmaceutically acceptable salts thereof. 展开▼
机译:可用作促甲状腺激素释放激素降解外切酶(TRH-DE)活性抑制剂的肽衍生物具有式I a Sup>: <图像alt =“嵌入式图像” file =“ US20060293247A1-20061228-C00001.GIF” he =“ 29.21mm” imgContent =“ chem” imgFormat =“ GIF” wi =“ 43.35mm“ /> 化学>其中: R 1 Sup>是具有一个或多个杂原子的可选取代的4、5或6元杂环,其中至少一个碳原子被O取代或S; ListItem> X 1 Sup>是-CO-或-CS-或-CH 2 Sub> CO-或CH(R 4 Sup>)其中R 4 Sup>是H或可选取代的烷基或-COOH或-COOR 11 Sup>其中R 11 Sup>是任选取代的烷基; ListItem> X 2 Sup>和X 3 Sup>(可以相同或不同)是-CO -或-CS-; Z为-CH 2 Sub>-或-S-或-O-或-NH-; Q是O或S; ListItem> R 2 Sup>是H或可选取代的烷基或可选取代的碳环; ListItem> R 3 Sup>是H或可选取代的烷基或可选取代的单环或多环,可选具有一个或多个杂原子在环中并且可选地是稠环;或R 2 Sup>和R 3 Sup>一起形成任选取代的单环或多环,所述单环或多环任选地在环中具有一个或多个杂原子并且任选地是稠合环; ListItem> R 5 Sup>和R 6 Sup>(可能相同或不同)是H,或低级烷基; ListItem> R 7 Sup>和R 8 Sup>(可能相同或不同)是H,或任选取代的低级烷基;或 ListItem> R 9 Sup>和R 10 Sup>(可能相同或不同)是H,或任选取代的烷基,或任选取代的碳环; ListItem> Y为—(CH 2 Sub>) n Sub> —其中n为0、1、2或3,当R 2 Sup>和R 3 Sup>形成环n的一部分时为0;或及其药学上可接受的盐。 ListItem> UnorderedList> ListItem> UnorderedList>
展开▼